Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald
Globe Newswire•18/08/2026•16:15 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.